Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Arabinofuranosyl residues on substituted xylan are key structural components of arabinoxylan, a major hemicellulose found in the cell walls of cereal grains such as wheat, rye, and barley (Scheller & Ulvskov, 2010). These residues consist of alpha-L-arabinofuranose units linked to the C(O)-2 and/or C(O)-3 positions of the beta-1,4-linked D-xylopyranosyl backbone. The pattern and degree of this substitution significantly influence the physicochemical properties of the polymer, including its water solubility, viscosity, and susceptibility to enzymatic degradation (Izydorczyk & Biliaderis, 1995). While not a traditional human therapeutic protein target, these residues serve as critical substrates for various carbohydrate-active enzymes (CAZymes), such as alpha-L-arabinofuranosidases, which are utilized in industrial biotechnology and as digestive aids to improve the nutritional value of animal feed and human diets. In the human gut, these residues are fermented by specific microbiota, such as Bifidobacterium species, leading to the production of beneficial short-chain fatty acids (SCFAs) like butyrate and propionate, which play roles in maintaining intestinal health and metabolic homeostasis (Riviere et al., 2016).
Enzymatic hydrolysis of the alpha-1,2 or alpha-1,3 glycosidic linkages by specific glycoside hydrolases (such as GH43 and GH51 families) to release arabinose and expose the xylan backbone for further degradation by xylanases.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Arabinofuranosyl residues on substituted xylan (AX).